1. The whole of this instrument

1 October 2018

1

adhesive removers and non-medicated skin cleansers relating to colostomy and ileostomy

2

antiperspirant preparations that derive their antiperspirant properties from inorganic salts of aluminium, zinc or zirconium only

3

dental bleaches and dental whiteners

4

devices for measuring alcohol content in body fluids or exhaled air

5

disinfectant and sterilant gases

6

drinking water purification and treatment equipment

7

ear candles

8

hair bleaches, hair dyes, hair-colorants and hair-perming preparations

9

household and personal aids, or furniture and utensils, for people with disabilities

10

incontinence pads, mattress overlays and mattress protectors

11

menstrual pads other than tampons and menstrual cups

12

sanitation, environmental control and environmental detoxification equipment

13

topical preparations applied to the nails to harden, or deter the biting of, nails

14

products intended for application to the lips, that contain sunscreen, and do not contain any substance included in Schedules 2, 3, 4 or 8 to the Poisons Standard, in relation to which one of the following two paragraphs applies:

(a)     for a product imported into, or manufactured in, Australia before 1 August 2018, both:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:1998 or AS/NZS 2604:2012; and

(ii)      any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 6.2 and 6.3 of AS/NZS 2604: 1998 or clauses 5 and 6 of AS/NSZ 2604:2012; or

(b)    for a product imported into, or manufactured in, Australia on or after 1 August 2018, all of the following:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:2012; and

(ii)      any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 5 and 6 of AS/NSZ 2604:2012; and

(iii)    if the product’s label states a protection factor, the label meets the requirements of clauses 7.1 and 7.3 of AS/NZS 2604: 2012; and

(iv)    the product must meet the performance requirements for a broad-spectrum product set out in clause 6.3 of AS/NZS 2604: 2012 and Table 1 in clause 5.2 of AS/NZS 2604: 2012

15

tinted bases and foundations, such as liquids, pastes or powders, that contain sunscreen, and do not contain any substance included in Schedules 2, 3, 4 or 8 to the Poisons Standard, in relation to which one of the following two paragraphs applies:

(a)     for a product imported into, or manufactured in, Australia before 1 August 2018, both:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:1998 or AS/NZS 2604:2012; and

(ii)      any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 6.2 and 6.3 of AS/NZS 2604: 1998 or clauses 5 and 6 of AS/NSZ 2604:2012; or

(b)    for a product imported into, or manufactured in, Australia on or after 1 August 2018, all of the following:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:2012; and

(ii)      any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 5 and 6 of AS/NSZ 2604:2012; and

(iii)    if the product’s label states a protection factor, the label meets the requirements of clauses 7.1 and 7.3 of AS/NZS 2604: 2012; and

(iv)    the product must meet the performance requirements for a broad-spectrum product set out in clause 6.3 of AS/NZS 2604: 2012 and Table 1 in clause 5.2 of AS/NZS 2604: 2012

1

anti-acne skin care products, including spot treatments, cleansers, face scrubs and masks, that do not contain any substance included in Schedules 2, 3, 4 or 8 to Poisons Standard

when advertised or presented for supply as controlling or preventing acne only through cleansing, moisturising, exfoliating or drying the skin

2

antibacterial skin care products that do not contain any substance included in Schedules 2, 3, 4 or 8 to the Poisons Standard

when advertised or presented for supply as being active against bacteria and not advertised or presented for supply as being:

(a)     active against viruses, fungi or other microbial organisms (other than bacteria); or

(b)    for use in connection with disease, disorders or medical conditions; or

(c)     active against a named bacterium that is known to be associated with a disease, disorder or medical condition; or

(d)    for use in connection with piercing of the skin or mucous membrane, for cosmetic or any other purpose; or

(e)     for use in connection with any procedure associated with the risk of transmission of disease from contact with blood or other bodily fluids; or

(f)     for use before physical contact with a person who is accessing medical or health services, or who is undergoing any medical or health care procedure; or

(g)    for use in connection with a procedure involving venepuncture or delivery of an injection

3

anti-dandruff hair care products

when advertised or presented for supply as controlling or preventing dandruff only through cleansing, moisturising, exfoliating or drying the scalp

4

compressed gases

when used as a power source for medical devices

5

moisturising skin care products, that contain sunscreen, and do not contain any substance included in Schedules 2, 3, 4 or 8 to the Poisons Standard, for dermal application, including anti-wrinkle, anti-ageing and skin whitening products, in relation to which one of the following two paragraphs applies:

(a)     for a product imported into, or manufactured in, Australia before 1 August 2018, both:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:1998 or AS/NZS 2604:2012; and

(ii)      any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 6.2 and 6.3 of AS/NZS 2604: 1998 or clauses 5 and 6 of AS/NSZ 2604:2012; or

(b)    for a product imported into, or manufactured in, Australia on or after 1 August 2018, all of the following:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:2012; and

(ii)      the product meets the performance requirements for a broad-spectrum product set out in clause 6.3 of AS/NZS 2604:2012 and Table 1 in clause 5.2 of AS/NZS 2604:2012; and

(iii)    any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 5 and 6 of AS/NSZ 2604:2012; and

(iv)    if the product’s label states a protection factor, the label meets the requirements of clauses 7.1 and 7.3 of AS/NZS 2604: 2012

when the product:

(a)     is not advertised or presented for supply as having a sun protection factor of more than 15; and

(b)    is not advertised or presented for supply as being water-resistant;
and

(c)     if the product is not stable for at least 36 months – includes an expiry date on its label; and

(d)    has a pack size not larger than 300mL or 300g; and

(e)     except in the manner provided below, does not have any therapeutic claims made in relation to it, including claims about skin cancer; and

therapeutic claims made in relation to the product are limited to those in relation to premature ageing in connection with sun exposure, and are only made if the product meets the performance requirements for broad-spectrum product set out in:

(a)     clause 7.2 of AS/NZS 2604:1998; or

(b)    both clause 6.3 of AS/NZS 2604:2012 and Table 1 in clause 5.2 of AS/NZS 2604:2012

6

oral hygiene products for the care of the teeth and the mouth, including dentifrices, mouth washes and breath fresheners, that do not contain any substance included in Schedules 2, 3, 4 or 8 to Poisons Standard

when advertised or presented for supply, the following two paragraphs apply:

(a)     the only benefits claimed to result from the use of the product is consequential on improvements to oral hygiene, including for the prevention of tooth decay or the use of fluoride for the prevention of tooth decay; and

(b)    benefits in relation to such other diseases or aliments, such as gum or other oral disease or periodontal condition, are not claimed to result from use of the product

7

packs and kits containing medical devices for the prevention of blood borne and sexually transmissible diseases where each individual therapeutic good contained within the packs or kits is already included on the Register

when advertised or presented for supply as a part of a Government endorsed health promotion program, having been expressly authorised by that Government as part of that program

8

piped medical gas systems

when installed and used in compliance with AS 2896–2011

9

preparations containing a sunscreening substance, if the primary purpose of the preparation is neither protection from solar radiation nor another therapeutic purpose

when the preparation is not advertised or presented for supply with:

(a)     a statement of claimed sun protection factor; or

(b)    a description of a claimed sun protection factor; or

(c)     a reference to another therapeutic use in respect of the preparation

10

sunbathing skin care products, such as oils, creams, gels, tanning products without sun and after-sun care products, that contain sunscreen with a sun protection factor of at least 4 and not more than 15, and do not contain any substance included in Schedules 2, 3, 4 or 8 to the Poisons Standard, in relation to which one of the following two paragraphs applies:

(a)     for a product imported into, or manufactured in, Australia before 1 August 2018, both:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:1998 or AS/NZS 2604:2012; and

(ii)      any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 6.2 and 6.3 of AS/NZS 2604: 1998 or clauses 5 and 6 of AS/NSZ 2604:2012; or

(b)    for a product imported into, or manufactured in, Australia on or after 1 August 2018, all of the following:

(i)        the product is a secondary sunscreen product within the definition of secondary sunscreen product in AS/NZS 2604:2012; and

(ii)      the product meets the performance requirements for a broad-spectrum product set out in clause 6.3 of AS/NZS 2604:2012 and Table 1 in clause 5.2 of AS/NZS 2604:2012; and

(iii)    any protection factor or equivalent category description stated on the product’s label is in accordance with clauses 5 and 6 of AS/NSZ 2604:2012; and

(iv)    if the product’s label states a protection factor, the label meets the requirements of clauses 7.1 and 7.3 of AS/NZS 2604: 2012

when the product:

(a)     is not advertised or presented for supply as having a sun protection factor of more than 15; and

(b)    is not advertised or presented for supply as being water-resistant; and

(c)     if the product is not stable for at least 36 months – includes an expiry date on its label;

(d)    has a pack size not larger than 300mL or 300g; and

(e)     except in the manner provided below, does not have any therapeutic claims made in relation to it, including claims about skin cancer; and

therapeutic claims made in relation to the product are limited to those in relation to premature ageing in connection with sun exposure, and are only made if the product meets the performance requirements for broad-spectrum product set out in:

(a)     clause 7.2 of AS/NZS 2604:1998; or

(b)    both clause 6.3 of AS/NZS 2604:2012 and Table 1 in clause 5.2 of AS/NZS 2604:2012

11

therapeutic goods for retaining, cushioning or repairing dentures

when advertised or presented for supply to the ultimate consumer